The role of semaphorins in cardiovascular diseases: Potential therapeutic targets and novel biomarkers.
Zheng YinJishou ZhangShuwan XuJianfang LiuYao XuJunping YuMengmeng ZhaoWei PanMenglong WangJun WanPublished in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2022)
Semaphorins (Semas), which belongs to the axonal guidance molecules, include 8 classes and could affect axon growth in the nervous system. Recently, semaphorins were found to regulate other pathophysiological processes, such as immune response, oncogenesis, tumor angiogenesis, and bone homeostasis, through binding with their plexin and neuropilin receptors. In this review, we summarized the detailed role of semaphorins and their receptors in the pathological progression of various cardiovascular diseases (CVDs), highlighting that semaphorins may be potential therapeutic targets and novel biomarkers for CVDs.
Keyphrases
- cardiovascular disease
- immune response
- spinal cord injury
- type diabetes
- human health
- bone mineral density
- risk assessment
- coronary artery disease
- toll like receptor
- optic nerve
- vascular endothelial growth factor
- inflammatory response
- transcription factor
- body composition
- dna binding
- cardiovascular events
- bone loss
- optical coherence tomography